Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Intraprostatic injection and high-frequency thermotherapy are more effective for treating prostatitis after TURP than antibiotics, tamsulosin, and finasteride.

Treatments for urinary symptoms often cause ejaculatory problems.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Pregnant female urologists should avoid certain drugs and use protective measures to stay safe.

Alpha1-blockers effectively improve urinary symptoms in BPH, with alfuzosin and tamsulosin having fewer side effects.

Both terazosin and baclofen effectively reduce pain in young men with chronic testicular pain, with no difference in their effectiveness.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Ultrasound shows 96% of young men with erectile dysfunction after using finasteride have abnormal penile tissue.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Sonirid Duo effectively treats benign prostatic hyperplasia.

Men with BPH should discuss potential sexual side effects with doctors before treatment, as some treatments can affect ejaculation.